`
`Filed on behalf of:
`
`By:
`
`Mylan Pharmaceuticals Inc.
`Joseph M. Reisman
`Jay R. Deshmukh
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 Main Street, 14th Floor
`
`Irvine, CA 92614
`Fax: (949) 760—9502
`Ph.: (949) 760—0404
`E-mail: BoxMylan@knobbe.com
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`NOVEN PHARMACEUTICALS, INC.
`
`AND MYLAN PHARMACEUTICALS INC.,
`
`Petitioners
`
`V.
`
`NOVARTIS AG AND LTS LOHMANN THERAPIE-SYSTEME AG,
`
`Patent Owners
`
`Case No. 113112014005491
`
`Patent 6,316,023 B1
`
`PETITIONER MYLAN PHARMACEUTICALS INC.’S UPDATED
`
`MANDATORY NOTICE INFORMATION UNDER 37 C.F.R. § 42.8(a)(3)
`
`1 Case IPR2015-00265 has been joined with this proceeding.
`
`
`
`IPR2014-00549
`
`Mylan V. Novartis
`
`Pursuant to 37 C.F.R. § 42.8, Petitioner, Mylan Pharmaceuticals Inc., hereby
`
`submits an updated mandatory notice in connection with the above-captioned Inter
`
`Partes Review of US. Patent 6,335,023.
`
`A.
`
`Real Parfl—In-Interest
`
`No change.
`
`B.
`
`Related Matters
`
`No change.
`
`C.
`
`Lead and Back—Up Counsel
`
`Petitioner Mylan Pharmaceuticals, Inc. provides notice that
`
`it
`
`is adding
`
`Benjamin B. Anger and Kerry S. Taylor of Knobbe, Martens, Olson & Bear, LLP
`
`as additional back up counsel.
`
`All other counsel information remains the same.
`
`Contact information for Mr. Anger and Mr. Taylor is as follows:
`
`Benjamin B. Anger (Reg. No. 62,207)
`Postal and Hand-Delivery Address:
`Knobbe, Martens, Olson & Bear LLP
`
`2040 Main Street, 14th Floor
`
`Irvine, CA 92614
`Ph.: (949) 760—0404
`Fax: (949) 760—9502
`Email: BoxMylan@knobbe.com
`
`
`
`IPR2014-00549
`
`Mylan V. Novartis
`
`Kerry S. Taylor (Reg. No. 43,947)
`Postal and Hand—Delivery Address:
`Knobbe, Martens, Olson & Bear LLP
`2040 Main Street, 14th Floor
`
`Irvine, CA 92614
`Ph.: (949) 760—0404
`Fax: (949) 760-9502
`Email: BoxMylan@knobbe.com
`
`D,
`
`Service Information
`
`No change.
`
`Dated: M42 Z?! My
`
`Respectfully submitted,
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`
`By: Q1? z 2; fix
`
`oseph M. Reisman
`Reg. No. 43,878
`Customer No. 20,995
`
`Attorneys for Petitioner
`MYLAN PHARMACEUTICALS INC.
`
`(949) 760—0404
`
`
`
`IPR2014~00549
`
`Mylan V. Novartis
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that a true and correct copy of the foregoing PETITIONER
`
`MYLAN PHARMACEUTICALS
`
`INC.’S UPDATED MANDATORY
`
`NOTICE INFORMATION UNDER 37 C.F.R. § 42.8(a)(3) is being served on
`
`May 20, 2015, Via email pursuant to 37 C.F.R. § 42.6(e) per agreement of the
`
`parties, to counsel for Novartis AG and LTS Lohmann Therapie—Systeme AG at
`
`the address below:
`
`ExelonPatchIPRngchscom
`
`Raymond R. Mandra
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`
`New York, NY 10104
`
`Dated: M52 47/65 73% ”
`
`20712142
`051915
`
`er/(f/é’v A
`
`
`.
`
`J seph M. Reisman, Reg. No. 43,878
`Attorney for Petitioner
`Mylan Pharmaceuticals Inc.
`
`